Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.80%
#2 Movement Movement +11.34%
#3 Victoria VR Victoria VR +7.37%
#4 DMT-NAT DMT-NAT +5.95%
#5 Cryptopia Cryptopia +5.23%
#6 COTI COTI +4.96%
#7 Lisk Lisk +4.73%
#8 Pons Pons +4.67%
#9 MarsCoin MarsCoin +4.33%
#10 Jito Jito +3.85%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
TetraLogic Pharmaceuticals Corporation TetraLogic Pharmaceuticals Corporation

TetraLogic Pharmaceuticals Corporation

TLOG
Classifica tra le azioni #42528
TetraLogic Pharmaceuticals Corporation operates as a clinical-stage... TetraLogic Pharmaceuticals Corporation operates as a clinical-stage biopharmaceutical firm, concentrating its efforts on identifying and advancing small-molecule treatments for cancer and infectious diseases. The company's development pipeline features two key clinical-stage drug candidates: birinapant and SHAPE. Birinapant, a small molecule, functions as a Second Mitochondrial Activator of Caspases (SMAC) mimetic, promoting programmed cell death, or apoptosis, in compromised cells. SHAPE, another proprietary compound, is a histone deacetylase (HDAC) inhibitor intended for topical administration to address early-stage cutaneous T-cell lymphoma. Furthermore, TetraLogic Pharmaceuticals has a research collaboration with the Walter and Eliza Hall Institute of Medical Research to explore the application of SMAC-mimetics, including birinapant, in treating infectious diseases. Founded in 2001 as Gentara Corporation, the company adopted its current name, TetraLogic Pharmaceuticals Corporation, in January 2006 and maintains its headquarters in Malvern, Pennsylvania.
Prezzo delle azioni
$0.00004
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$979.00
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-96.00%
Paese
US
Scambia TetraLogic Pharmaceuticals Corporation (TLOG)

Categoria

Healthcare
Storico del prezzo dell'azione per TetraLogic Pharmaceuticals Corporation (TLOG)
Prezzo di chiusura più alto: $0.00 il 2026-08-01

Prezzo di chiusura più basso: $7.80 il 2013-12-01
Storico del prezzo dell'azione di TetraLogic Pharmaceuticals Corporation dal 2013 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 0.00%
2025 17.69%
2024 -14.40%
2023 -62.44%
2022 -94.10%
2021 -63.46%
2020 -64.19%
2019 262.70%
2018 -72.55%
2017 -41.80%
2016 -96.37%
2015 -69.79%
2014 -34.13%
2013 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.69%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 18.09%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -7.16%
KR